Company · CIK 2114044

# Hemab Therapeutics Holdings, Inc.

| CIK | [2114044](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002114044) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | COAG (Nasdaq) |
| First annual or quarterly report | 2026-05-21 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294989 | IPO Final prospectus | 2026-04-10 | 2026-05-01 | 6 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-01 | [424B4](https://www.sec.gov/Archives/edgar/data/2114044/000119312526201458/0001193125-26-201458-index.htm) Final prospectus | 333-294989 | 0001193125-26-201458 |
| 2026-04-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2114044/999999999526001409/9999999995-26-001409-index.htm) Declared effective | 333-294989 | 9999999995-26-001409 |
| 2026-04-30 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2114044/000119312526193885/0001193125-26-193885-index.htm) Amendment | 333-294989 | 0001193125-26-193885 |
| 2026-04-28 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2114044/000119312526186964/0001193125-26-186964-index.htm) Amendment | 333-294989 | 0001193125-26-186964 |
| 2026-04-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/0001193125-26-178809-index.htm) Amendment | 333-294989 | 0001193125-26-178809 |
| 2026-04-10 | [S-1](https://www.sec.gov/Archives/edgar/data/2114044/000119312526151378/0001193125-26-151378-index.htm) Registration filed | 333-294989 | 0001193125-26-151378 |
| 2026-02-27 | [DRS](https://www.sec.gov/Archives/edgar/data/2114044/000119312526081986/0001193125-26-081986-index.htm) Draft made public | 377-09105 | 0001193125-26-081986 |

[All filings of this company](https://equitycapital.markets/filings?cik=2114044) · [CSV](https://equitycapital.markets/filings.csv?cik=2114044)

---
Source page: https://equitycapital.markets/company/2114044 · Data: U.S. SEC EDGAR · CC BY 4.0